Three different avian influenza strains are currently circulating in birds worldwide and being monitored by global health agencies for human infection risk. Understanding what each one actually represents — and for whom — requires separating genuine occupational risk from population-level pandemic risk that does not yet exist.
The honest summary: the risk to the general American public from avian influenza in mid-2026 is low. The risk to specific populations — dairy farm workers, poultry workers, and people in close contact with sick animals — is real and documented. And the underlying surveillance concern — that any of these strains could acquire the ability to spread efficiently between humans — remains a legitimate forward-looking public health priority.
Why This Matters
Multiple avian influenza strains circulating simultaneously create a public communication challenge: the cumulative impression can be alarming, but the actual risk is highly specific to the pathway of exposure. Understanding the three strains, their distinct characteristics, and who they are actually infecting in 2026 provides the calibrated picture that neither dismisses the concern nor overstates the threat.
H5N1: The Strain with Active U.S. Spread
H5N1 is the avian influenza strain most directly affecting Americans right now. Since its emergence in U.S. dairy cattle herds in early 2024, H5N1 has produced 71 confirmed human cases in the United States through early 2026, with 2 deaths. All confirmed human cases have been linked to direct animal contact — typically dairy farm workers handling infected cattle or milking equipment, with some linked to poultry farm exposure. Many people infected had unprotected workplace exposures without using recommended personal protective equipment.
No human-to-human transmission of H5N1 has been confirmed in the United States. The risk is occupational and contact-based.
H5N1 has also been detected in wild birds, domestic poultry flocks, and wild mammals across the United States and globally. As of June 2026, 1,022 cumulative human cases of H5N1 have been reported worldwide since 1997, with historically high case fatality rates when the exposure was to poultry-origin strains — though the cattle-adapted H5N1 clade currently circulating in U.S. dairy herds has thus far been associated with milder illness in the human cases detected.
Who faces real H5N1 risk: Dairy workers, poultry farm workers, farm veterinarians, and anyone in close, unprotected contact with cattle or poultry in states where H5N1 is circulating. PPE use (eye protection, N95 respirators) during animal contact reduces risk substantially.
H5N2: One Fatal Human Case, No Broader Spread
H5N2 caused a single, notable human case in 2024: a fatality in Mexico — the first confirmed human H5N2 infection ever documented globally. The 59-year-old patient had severe pre-existing conditions, including diabetes, renal failure, and peritonitis, and investigators were unable to conclusively identify an animal exposure source. The WHO noted that the H5N2 virus detected was of low pathogenicity and was not definitively linked to the cause of death. No additional human H5N2 infections have been detected since.
The Mexico case was significant because it demonstrated that H5N2 can infect humans — but the absence of additional cases since then, despite ongoing H5N2 circulation in poultry, suggests no sustained human transmission potential has developed. The CDC classifies the current human infection risk from H5N2 as low.
Who faces real H5N2 risk: Poultry workers and veterinarians in direct contact with infected flocks. The risk to the general public is negligible based on current data.
H9N2: Active Human Cases in 2026
H9N2 is less familiar to most readers than H5N1 but has a longer history of sporadic human infections. Unlike H5N1, H9N2 does not typically cause severe illness in humans — cases have generally been mild or moderate — but the strain is concerning because it circulates widely in poultry and has repeatedly served as a genetic «donor» to other influenza strains, contributing genetic segments to H5N1 and H7N9 through recombination.
In Q1 2026, five human H9N2 cases were reported globally — four from China and one from Italy, according to WHO surveillance data. The Italy case involved an adult male who had traveled to Senegal, where he was likely exposed, and was detected after arrival in Italy — WHO issued a Disease Outbreak Notice for that case in April 2026. All cases involved direct or indirect poultry contact, and none were transmitted to close contacts. No human H9N2 cases have been confirmed in the United States.
The WHO’s March 2026 human-animal interface summary continues to assess the risk to the general population from H9N2 as low, noting the strain has not acquired the ability to transmit easily among humans. The strain’s widespread circulation in poultry and its history of genetic recombination still make it a priority surveillance target.
Who faces real H9N2 risk: Poultry workers and individuals in direct contact with infected poultry, primarily in China and parts of Africa (where travel-linked exposure has now also been documented). The current U.S. risk is very low.
The Shared Surveillance Concern
What unites the monitoring of all three strains is a common underlying concern that applies to all avian influenza viruses: the possibility that a circulating avian strain could acquire mutations — through either natural evolution or genetic recombination with human influenza strains — that allow efficient human-to-human transmission. That scenario has not occurred. But the more opportunities avian influenza viruses have to infect humans, the more chances they have to acquire those mutations.
This is the logic behind aggressive surveillance, early case detection, and occupational protection for the workers most exposed — not because the current risk to the general population is high, but because maintaining the earliest possible warning system is the most effective tool for detecting the kind of viral change that would escalate the risk profile.
What Doctors and Experts Say
The CDC’s current assessment of the risk to the general public from all three avian influenza strains is consistent: low. The agency emphasizes that none of the three strains currently transmits sustainably from person to person, and that the human cases identified in 2026 are consistent with the known pattern of sporadic human infections from direct animal contact rather than emerging human-to-human spread.
The concern public health researchers consistently emphasize is not the current risk level but the response readiness: ensuring that occupational exposure protections are in place, that surveillance systems can detect the first signs of human-to-human transmission, and that the U.S. government maintains the stockpile, infrastructure, and vaccine production capacity to respond to a pandemic strain if one emerges. CIDRAP at the University of Minnesota provides continuous tracking of avian flu developments for those following the surveillance picture closely.
What the Evidence Shows — and What It Does Not
The evidence clearly shows: three avian influenza strains are infecting humans sporadically through direct animal contact in 2026. None is transmitting between humans. The human case counts are low. The risk to people without animal contact is negligible.
The evidence does not show: an imminent pandemic risk, any confirmed evidence of human-to-human transmission, or any evidence that the current strains have acquired the key mutations associated with pandemic potential.
Who Faces the Greatest Risk?
- U.S. dairy farm workers in contact with H5N1-positive cattle herds — particularly those without adequate protective equipment
- Poultry workers on farms affected by H5N1 or H5N2 outbreaks
- Veterinarians, wildlife biologists, and researchers working with infected or potentially infected animals
- Poultry workers in China and parts of Africa and Southeast Asia where H9N2 circulates extensively
- Anyone without proper PPE who handles sick or dead birds
What You Can Do Now
Farm and poultry workers: Use appropriate PPE — N95 or higher respiratory protection and eye protection — when working with potentially infected animals or environments. Report any flu-like illness after animal contact to your occupational health provider or state health department.
General public: Do not handle sick or dead wild birds. If you find a dead bird, use gloves and a bag to dispose of it without direct contact, or contact your local animal control.
Travel to regions with active H9N2 or H5N1 poultry outbreaks: Avoid live animal markets and direct contact with poultry.
Monitor the CDC’s Bird Flu Current Situation page and A(H5) surveillance data for current case counts and updates.
What Happens Next
CDC and WHO will continue surveillance updates on all three strains. The dairy cattle H5N1 situation in the United States — which has not resolved — is being actively monitored for any changes in clinical severity in farm workers or any evidence of farm-to-farm human spread. MedicalDaily will report on any significant change in risk assessment for any of the three circulating strains.
The Bottom Line
Three avian influenza strains — H5N1, H5N2, and H9N2 — are all being monitored in 2026 for human infection risk. H5N1 has produced 71 confirmed U.S. human cases through direct animal contact. H5N2 caused one fatal human case in Mexico in 2024 with no subsequent cases. H9N2 caused five global human cases in Q1 2026. None transmits between people. The general public is not at meaningful risk. Dairy and poultry workers who lack protective equipment are. That distinction matters — and so does the surveillance system designed to catch any viral change before it becomes something larger.
